Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alprazolam submitted by Mylan Pharmaceuticals, contributing to the existing approval for this generic benzodiaze…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)